Waters (WAT) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $3.05
- Estimate
- $3.01
- Surprise
- +1.4%
- Score at report (before → after)
- 6.1 → 6.4/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Waters (WAT) beat the $3.01 estimate with adjusted EPS of $3.05 — a modest 1.4% upside surprise. TrendMatrix's engine moved from Hold (6.1/10) to Buy (Wait) at 6.4/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates WAT Hold at 5.9/10.
4 of the last 4 quarters beat the estimate; this quarter's +1.4% surprise compares with a +6.1% four-quarter average. Next scheduled report: 2026-11-03.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Analyst target reached - limited upside remaining
- Near 52-week high (4.0% away)
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $436.43
- Price target
- $445.45
- Stop
- $410.53
- Upside to target
- +2.1%
The stock trades at 110.5× trailing but 26.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-07 — shown for context, not personalized investment advice.
WAT at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Diagnostics & Research
- Market cap
- $42.85B
- P/E (fwd)
- 26.4
- P/E (ttm)
- 110.5
- 52-week range
- $282.77–$454.54
- Off 52-week high
- 4.0%
- RSI (14)
- 60
- Volume vs avg
- 1.37×
- Score today
- 5.9/10